RELAY THERAPEUTICS INC. - COMMON STOCK

Relay Therapeutics Announces $30 Million Private Placement Financing

08 Jan 2024 07:00:32 By Nasdaq GlobeNewswire

Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

02 Jan 2024 16:05:12 By Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference

07 Nov 2023 16:05:18 By Nasdaq GlobeNewswire

Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights

02 Nov 2023 16:05:42 By Nasdaq GlobeNewswire

Relay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023

26 Oct 2023 16:05:51 By Nasdaq GlobeNewswire

Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors

12 Oct 2023 16:05:00 By Nasdaq GlobeNewswire

Relay Therapeutics to Present Clinical Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

18 Sep 2023 16:05:42 By Nasdaq GlobeNewswire

Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights

08 Aug 2023 16:02:09 By Nasdaq GlobeNewswire

Relay Therapeutics to Announce Second Quarter 2023 Financial Results and Corporate Highlights on August 8, 2023

01 Aug 2023 16:05:24 By Nasdaq GlobeNewswire

Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008

25 May 2023 17:01:31 By Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

24 May 2023 16:05:03 By Nasdaq GlobeNewswire

Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights

04 May 2023 16:05:47 By Nasdaq GlobeNewswire

Relay Therapeutics to Announce First Quarter 2023 Financial Results and Corporate Highlights

27 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

19 Apr 2023 07:30:00 By Nasdaq GlobeNewswire

Relay Therapeutics Announces Initial Clinical Data Demonstrating that RLY-2608 Selectively Targets Multiple PI3Kα Mutations

18 Apr 2023 10:40:00 By Nasdaq GlobeNewswire

Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR

06 Mar 2023 07:30:00 By Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

01 Mar 2023 07:30:00 By Nasdaq GlobeNewswire

Relay Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights

23 Feb 2023 16:05:01 By Nasdaq GlobeNewswire

Relay Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights

16 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day

02 Feb 2023 07:30:00 By Nasdaq GlobeNewswire